CTLA4 and neoplasm: Thus, TAM/microglia repolarization toward a more pro-inflammatory/anti-tumoral phenotype will be more beneficial in combination with other immune-related therapies such as anti-PD1, anti-CTLA-4, or CAR-T, or even just standard chemo-or radiation therapy improving tumor growth reduction and overall patient survival.